Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Exercise of Options

20 Mar 2013 10:45

AVINGTRANS PLC - Exercise of Options

AVINGTRANS PLC - Exercise of Options

PR Newswire

London, March 20

Avingtrans Plc ("Avingtrans" or the "Company" or the "Group") Exercise of Share Options and Director Dealings

Avingtrans (AIM:AVG), a manufacturer of critical components and associatedservices to the global aerospace, energy and medical sectors announces that itwas notified on 19 March 2013 of the transactions described below in theordinary shares of the Company.

On 19 March 2013, the Company was notified of the exercise of 90,000 optionsover ordinary shares of 5p each in the Company ("Ordinary Shares") to directorsand senior managers, of which 50,000 options have an exercise price of 40.0pence and 40,000 options have an exercise price of 35.0 pence.

Details of the exercise of options by Stephen King a director of the Company,the sale of shares and the subsequent beneficial holdings of such directorfollowing the transactions set out below:

Director Number of Options Number of Ordinary Beneficial interest exercised at 40p Shares Sold in Ordinary Shares after the transaction Stephen King 50,000 10,000 175,000 Stephen King sold the 10,000 Ordinary Shares at a price of 95 pence per share.

Pursuant to the above transactions, Avingtrans announces that 90,000 ordinaryshares of 5p each in the Company have been allotted. Application has been madeto the London Stock Exchange for the new ordinary shares to be admitted totrading on AIM and it is expected that admission will take place on 26 March2013. The new ordinary shares will rank pari passu with the existing shares ofthe Company.

Subsequent to issue of the Ordinary Shares as above, the Company's total issuedshare capital is 27,049,397 Ordinary Shares. Avingtrans does not hold anyOrdinary Shares in treasury. Therefore, the total number of voting rights inAvingtrans is 27,049,397.

The above figure 27,049,397 may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Avingtrans under the FSA'sDisclosure and Transparency Rules.

Enquiries: Avingtrans plc 0115 949 9020 Steve McQuillan, CEO Stephen King, CFO

Numis Securities Limited 020 7260 1000

David Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

Newgate Threadneedle 020 7653 9850

(Financial PR) Josh Royston Heather Armstrong About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered componentsand services to the Aerospace, Energy and Medical markets worldwide.

The business is made up of 2 divisions: • Aerospace, engaged in the manufacture of rigid pipe assemblies,

fabrications and prismatic components - both metallic and composite - for

the global aerospace market and precision polishing of aircraft components

and;

• Energy and medical, engaged in the manufacture of machined and fabricated

pressure and vacuum vessels and components for the energy, medical, science

and research communities. Plus, design and manufacture of fabricated poles

and cabinets for roadside safety cameras and rail track signalling.

Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.